GV20 Therapeutics
bioxbh.comLocations
Cambridge, MA, USA · Shanghai, China
industry
Pharmaceuticals
Size
11-50 employees
Stage
Series B
founded in
2016
GV20 Therapeutics (https://gv20tx.com) was incorporated in 2016 with sites in Cambridge, USA, and Shanghai, China. The company utilizes high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets and discover and develop effective antibody drugs in cancer. GV20's proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment.
Something looks off?Open jobs at GV20 Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.